Free Trial

Absci Q3 2024 Earnings Report

Absci logo
$3.16 +0.17 (+5.69%)
(As of 01:15 PM ET)

Absci Earnings Headlines

Absci Co. (NASDAQ:ABSI) Receives $8.67 Average PT from Analysts
One coin could soar when Trump’s elected …
Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”
Absci management to meet virtually with KeyBanc
Absci (NASDAQ:ABSI) Stock, Option Chain
See More Absci Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Absci? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Absci and other key companies, straight to your email.

About Absci

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.

View Absci Profile

More Earnings Resources from MarketBeat